CIPO Patents = 4

EPO Patents = 2

Forward Citations = 8

Loading Chart...

5 inventors (with patents filed for the assignee):

Robert Joseph Devita (3 out of 20 patents)

Daniel De Roulet (3 out of 3 patents)

Kevan M Shokat (2 out of 54 patents)

4. Nicholas T Hertz (2 out of 4 patents)

5. Robert J DeVita (2 out of 21 patents)

5 patents: Sort by Forward Citations

1. 11427588 - Compositions and methods for treating neurodegenerative diseases and cardiomyopathy (2022-08-30),

2. 11414419 - Substituted purines for the treatment of neurodegenerative and mitochondrial diseases (2022-08-16),

3. 10851109 - Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease (2020-12-01),

4. 10723737 - Compositions and methods for treating neurodegenerative diseases and cardiomyopathy (2020-07-28),

5. 10167286 - Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease (2019-01-01),

Mitokinin, Inc. is a biotechnology company focused on developing novel therapeutics for neurodegenerative diseases. Our innovative approach targets mitochondrial dysfunction to address conditions such as Parkinson's disease. Through cutting-edge research and partnerships, we aim to bring new treatments to patients in need.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

5 Patents

#758 in San Francisco, CA

#12,057 in California

#51,569 in US

San Francisco, CA, United States of America

Mitokinin, Inc.

Forward Citations = 8

5 inventors:

Robert Joseph Devita (3 out of 20 patents)

Daniel De Roulet (3 out of 3 patents)

Kevan M Shokat (2 out of 54 patents)

4. Nicholas T Hertz (2 out of 4 patents)

5. Robert J DeVita (2 out of 21 patents)

Please report any incorrect information to [email protected]

4 patents (CIPO):

Please report any incorrect information to [email protected]

2 patents (EPO):

Please report any incorrect information to [email protected]